Advertisement

Annals of Surgical Oncology

, Volume 20, Issue 8, pp 2468–2476 | Cite as

Delay to Curative Surgery Greater than 12 Weeks Is Associated with Increased Mortality in Patients with Colorectal and Breast Cancer but Not Lung or Thyroid Cancer

  • Dong Wook Shin
  • Juhee Cho
  • So Young Kim
  • Eliseo Guallar
  • Seung Sik Hwang
  • BeLong Cho
  • Jae Hwan Oh
  • Ki Wook Jung
  • Hong Gwan Seo
  • Jong Hyock Park
Healthcare Policy and Outcomes

Abstract

Background

Surgery for cancer is often delayed due to variety of patient-, provider-, and health system–related factors. However, impact of delayed surgery is not clear, and may vary among cancer types. We aimed to determine the impact of the delay from cancer diagnosis to potentially curative surgery on survival.

Methods

Cohort study based on representative sample of patients (n = 7,529) with colorectal, breast, lung and thyroid cancer with local or regional disease who underwent potentially curative surgery as their first therapeutic modality within 1 year of cancer diagnosis. They were diagnosed in 2006 and followed for mortality until April 2011, a median follow-up of 4.7 years.

Results

For colorectal and breast cancers, the adjusted hazard ratios (95 % confidence intervals) for all-cause mortality comparing a surgical delay beyond 12 weeks to performing surgery within weeks 1–4 after diagnosis were 2.65 (1.50–4.70) and 1.91 (1.06–3.49), respectively. No clear pattern of increased risk was observed with delays between 4 and 12 weeks, or for any delay in lung and thyroid cancers. Concordance between the area of the patient’s residence and the hospital performing surgery, and the patient’s income status were associated with delayed surgery.

Conclusions

Delays to curative surgery beyond 12 weeks were associated with increased mortality in colorectal and breast cancers, suggesting that health provision services should be organized to avoid unnecessary treatment delays. Health care systems should also aim to reduce socioeconomic and geographic disparities and to guarantee equitable access to high quality cancer care.

Keywords

Breast Cancer Thyroid Cancer Treatment Delay Adjusted Hazard Ratio Large Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgment

This work was supported by a Grant from the Ministry of Health and Welfare (Grant 1210150) and received administrative support from the Ministry of Health and Welfare and National Health Insurance Corporation, Korea.

Conflict of interest

The authors declare no conflict of interest.

Supplementary material

10434_2013_2957_MOESM1_ESM.doc (33 kb)
Supplementary material 1 (DOC 33 kb)
10434_2013_2957_MOESM2_ESM.tif (751 kb)
Supplementary material 2. Restricted cubic splines of the probability of death by time tosurgery (TIFF 750 kb)

References

  1. 1.
    Fradet Y, Aprikian A, Dranitsaris G, Siemens R, Tsihlias J, Fleshner N. Does prolonging the time to bladder cancer surgery affect long-term cancer control? A systematic review of the literature. Can J Urol. 2006;13(Suppl 3):37–47.PubMedGoogle Scholar
  2. 2.
    Bardell T, Belliveau P, Kong W, Mackillop WJ. Waiting times for cancer surgery in Ontario: 1984–2000. Clin Oncol. 2006;18:401–9.CrossRefGoogle Scholar
  3. 3.
    Jewett M, Rendon R, Dranitsaris G, et al. Does prolonging the time to renal cancer surgery affect long-term cancer control: a systematic review of the literature. Can J Urol. 2006;13(Suppl 3):54–61.PubMedGoogle Scholar
  4. 4.
    Kawakami J, Hopman WM, Smith-Tryon R, Siemens DR. Measurement of surgical wait times in a universal health care system. Can Urol Assoc J. 2008;2:597–603.PubMedGoogle Scholar
  5. 5.
    Kulkarni GS, Urbach DR, Austin PC, Fleshner NE, Laupacis A. Longer wait times increase overall mortality in patients with bladder cancer. J Urol. 2009;182:1318–24.PubMedCrossRefGoogle Scholar
  6. 6.
    Mayo NE, Scott SC, Shen N, Hanley J, Goldberg MS, MacDonald N. Waiting time for breast cancer surgery in Quebec. CMAJ. 2001;164:1133–8.PubMedGoogle Scholar
  7. 7.
    Willcox S, Seddon M, Dunn S, Edwards RT, Pearse J, Tu JV. Measuring and reducing waiting times: a cross-national comparison of strategies. Health Aff (Millwood). 2007;26:1078–87.PubMedCrossRefGoogle Scholar
  8. 8.
    Lee CT, Madii R, Daignault S, et al. Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol. 2006;175:1262–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Wagner JL, Warneke CL, Mittendorf EA, et al. Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg. 2011;254:119–24.PubMedCrossRefGoogle Scholar
  10. 10.
    Saad F, Finelli A, Dranitsaris G, et al. Does prolonging the time to prostate cancer surgery impact long-term cancer control: a systematic review of the literature. Can J Urol. 2006;13(Suppl 3):16–24.PubMedGoogle Scholar
  11. 11.
    Bell D, Morash C, Dranitsaris G, et al. Does prolonging the time to testicular cancer surgery impact long-term cancer control: a systematic review of the literature. Can J Urol. 2006;13(Suppl 3):30–6.PubMedGoogle Scholar
  12. 12.
    Chang SS, Hassan JM, Cookson MS, Wells N, Smith JA Jr. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol. 2003;170:1085–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a surveillance, epidemiology, and end results-medicare analysis. Cancer. 2009;115:988–96.PubMedCrossRefGoogle Scholar
  14. 14.
    Mahmud SM, Fong B, Fahmy N, Tanguay S, Aprikian AG. Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: a population based study. J Urol. 2006;175:78–83.PubMedCrossRefGoogle Scholar
  15. 15.
    May M, Nitzke T, Helke C, Vogler H, Hoschke B. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder. Scand J Urol Nephrol. 2004;38:231–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Sanchez-Ortiz RF, Huang WC, Mick R, Van Arsdalen KN, Wein AJ, Malkowicz SB. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol. 2003;169:110–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Liedberg F, Anderson H, Mansson W. Treatment delay and prognosis in invasive bladder cancer. J Urol. 2005;174:1777–81.PubMedCrossRefGoogle Scholar
  18. 18.
    Nielsen ME, Palapattu GS, Karakiewicz PI, et al. A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int. 2007;100:1015–20.PubMedGoogle Scholar
  19. 19.
    Vujovic O, Yu E, Cherian A, et al. Effect of interval to definitive breast surgery on clinical presentation and survival in early-stage invasive breast cancer. Int J Radiat Oncol Biol Phys. 2009;75:771–4.PubMedCrossRefGoogle Scholar
  20. 20.
    Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer. 1999;79:858–64.PubMedCrossRefGoogle Scholar
  21. 21.
    Holmstrom B, Holmberg E, Egevad L, et al. Outcome of primary versus deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study. J Urol. 2010;184:1322–7.PubMedCrossRefGoogle Scholar
  22. 22.
    van den Bergh RC, Steyerberg EW, Khatami A, Aus G, Pihl CG, Wolters T, et al. Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes? Cancer. 2010;116:1281–90.PubMedCrossRefGoogle Scholar
  23. 23.
    Warlick C, Trock BJ, Landis P, Epstein JI, Carter HB. Delayed versus immediate surgical intervention and prostate cancer outcome. J Natl Cancer Inst. 2006;98:355–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Nguyen PL, Whittington R, Koo S, et al. The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma. Cancer. 2005;103:2053–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Won YJ, Sung J, Jung KW, et al. Nationwide cancer incidence in Korea, 2003–2005. Cancer Res Treat. 2009;41:122–31.PubMedCrossRefGoogle Scholar
  26. 26.
    Hwang EJ, Kang J, Kim HY, Cho JY, Shin DW. Regional variation in the supply of palliative care beds in Korea. Health Serv Manage Rev. 2009;3:31–9.Google Scholar
  27. 27.
    Lee JA, Park JH, Lee EJ, Kim SY, Kim Y, Lee SI. High-quality, low-cost gastrectomy care at high-volume hospitals: results from a population-based study in South Korea. Arch Surg. 2011;146:930–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat. 2006;99:313–21PubMedCrossRefGoogle Scholar
  29. 29.
    Comber H, Cronin DP, Deady S, Lorcain PO, Riordan P. Delays in treatment in the cancer services: impact on cancer stage and survival. Ir Med J. 2005;98:238–9.PubMedGoogle Scholar
  30. 30.
    Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209:180–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Reed AD, Williams RJ, Wall PA, Hasselback P. Waiting time for breast cancer treatment in Alberta. Can J Public Health. 2004;95:341–5.PubMedGoogle Scholar
  32. 32.
    Williams TE Jr, Satiani B, Thomas A, Ellison EC. The impending shortage and the estimated cost of training the future surgical workforce. Ann Surg. 2009;250:590–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Fleshner N, Dranitsaris G, Finelli A, Tsihlias J, Bell D, Gleave M. Surgical wait times for patients with urological cancers: a survey of Canadian surgeons. Can J Urol. 2006;13(Suppl 3):3–13.PubMedGoogle Scholar
  34. 34.
    Bilimoria KY, Ko CY, Tomlinson JS, et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253:779–85.PubMedCrossRefGoogle Scholar
  35. 35.
    Simunovic M, Gagliardi A, McCready D, Coates A, Levine M, DePetrillo D. A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontario. CMAJ. 2001;165:421–5.PubMedGoogle Scholar
  36. 36.
    Hillner BE, Smith TJ, Desch CE. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol. 2000;18:2327–40.PubMedGoogle Scholar
  37. 37.
    Payne S, Jarrett N, Jeffs D. The impact of travel on cancer patients’ experiences of treatment: a literature review. Eur J Cancer Care. 2000;9:197–203.CrossRefGoogle Scholar
  38. 38.
    Calman K, Hine D. A policy framework for commissioning cancer services: a report by the expert advisory group on cancer to the chief medical officers of England and Wales. London: Department of Health, 1995.Google Scholar
  39. 39.
    Iversen LH, Antonsen S, Laurberg S, Lautrup MD. Therapeutic delay reduces survival of rectal cancer but not of colonic cancer. Br J Surg. 2009;96:1183–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Canizares Carretero MA, Rivo Vazquez JE, Blanco Ramos M, Toscano Novella A, Garcia Fontan EM, Purrinos Hermida MJ. Influence of delay of surgery on the survival of patients with bronchogenic carcinoma. Arch Bronconeumol. 2007;43:165–70.PubMedCrossRefGoogle Scholar
  41. 41.
    Davies L, Welch HG. Thyroid cancer survival in the United States: observational data from 1973 to 2005. Arch Otolaryngol Head Neck Surg. 2010;136:440–4.PubMedCrossRefGoogle Scholar
  42. 42.
    ClinicalTrials.gov. Treatment decision-making among patients diagnosed with papillary microcarcinoma and their significant others. 2011. http://clinicaltrials.gov/ct2/show/NCT01392222.
  43. 43.
    Kern KA. Medicolegal analysis of the delayed diagnosis of cancer in 338 cases in the United States. Arch Surg. 1994;129:397–403.PubMedCrossRefGoogle Scholar
  44. 44.
    Hafstrom L, Johansson H, Ahlberg J. Does diagnostic delay of colorectal cancer result in malpractice claims? A retrospective analysis of the Swedish board of malpractice from 1995–2008. Patient Saf Surg. 2012;6:13PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2013

Authors and Affiliations

  • Dong Wook Shin
    • 1
    • 2
  • Juhee Cho
    • 3
    • 4
    • 5
  • So Young Kim
    • 6
  • Eliseo Guallar
    • 4
    • 7
  • Seung Sik Hwang
    • 8
  • BeLong Cho
    • 1
    • 2
  • Jae Hwan Oh
    • 9
  • Ki Wook Jung
    • 10
  • Hong Gwan Seo
    • 6
    • 11
  • Jong Hyock Park
    • 6
  1. 1.Department of Family Medicine and Health Promotion CenterSeoul National University HospitalSeoulRepublic of Korea
  2. 2.Cancer Survivorship ClinicSeoul National University Cancer HospitalSeoulRepublic of Korea
  3. 3.Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and TechnologySungkyunkwan UniversitySeoulRepublic of Korea
  4. 4.Department of EpidemiologyJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  5. 5.Department of Health, Behavior, and SocietyJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  6. 6.National Cancer Control Research InstituteNational Cancer CenterGoyangRepublic of Korea
  7. 7.Department of MedicineWelch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Medical InstitutionsBaltimoreUSA
  8. 8.Department of Social and Preventive MedicineInha UniversityIncheonRepublic of Korea
  9. 9.Center for Colorectal CancerNational Cancer CenterGoyangRepublic of Korea
  10. 10.Center for Thyroid CancerNational Cancer CenterGoyangRepublic of Korea
  11. 11.Center for Cancer Prevention and DetectionNational Cancer CenterGoyangRepublic of Korea

Personalised recommendations